Mitochondria in cancer stem cells: Achilles heel or hard armor

Trends Cell Biol. 2023 Aug;33(8):708-727. doi: 10.1016/j.tcb.2023.03.009. Epub 2023 May 1.

Abstract

Previous studies have shown that mitochondria play core roles in not only cancer stem cell (CSC) metabolism but also the regulation of CSC stemness maintenance and differentiation, which are key regulators of cancer progression and therapeutic resistance. Therefore, an in-depth study of the regulatory mechanism of mitochondria in CSCs is expected to provide a new target for cancer therapy. This article mainly introduces the roles played by mitochondria and related mechanisms in CSC stemness maintenance, metabolic transformation, and chemoresistance. The discussion mainly focuses on the following aspects: mitochondrial morphological structure, subcellular localization, mitochondrial DNA, mitochondrial metabolism, and mitophagy. The manuscript also describes the recent clinical research progress on mitochondria-targeted drugs and discusses the basic principles of their targeted strategies. Indeed, an understanding of the application of mitochondria in the regulation of CSCs will promote the development of novel CSC-targeted strategies, thereby significantly improving the long-term survival rate of patients with cancer.

Keywords: anticancer therapeutics; cancer stem cells; metabolism; mitochondria; mitochondrial morphology.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • DNA, Mitochondrial
  • Drug Resistance, Neoplasm*
  • Humans
  • Mitochondria* / drug effects
  • Mitochondria* / metabolism
  • Mitochondria* / ultrastructure
  • Mitophagy*
  • Neoplasms* / drug therapy
  • Neoplastic Stem Cells* / metabolism
  • Neoplastic Stem Cells* / ultrastructure

Substances

  • DNA, Mitochondrial
  • Antineoplastic Agents